The COCOON trial regimen halved grade 2 or higher dermatologic side effects compared to standard care in EGFR-mutant non-small cell lung cancer patients. A two-fold reduction in severe dermatologic ...

Optimizing Cardiovascular Health in Patients With Cancer: A Practical Review of Risk Assessment, Monitoring, and Prevention of Cancer Treatment–Related Cardiovascular Toxicity As cancer therapies ...

Dermatologic immune-related adverse events (irAEs) are one of many side effects of immunotherapy that can significantly affect patients’ quality of life and treatment success. New research is shedding ...

In a multicentre real-world study, treatment with amivantamab was associated with diverse dermatologic adverse events in patients with non-small cell lung cancer (NSCLC), with 65.9% developing ...

SYSTEMIC corticosteroid therapy has, since ACTH and cortisone were first used therapeutically, proved its value in the treatment of many dermatologic conditions. Although its application has been ...

There are various types of therapies that may be used in the management of dermatologic conditions. These can be broadly categorized as topical agents, dressings, systemic agents, laser and ...

Quantification of dose dependence and frequency of checkpoint inhibitor immune-mediated adverse events: A Bayesian model-based meta-analysis. A phase II trial with safety lead-in to evaluate the ...

Companies may potentially accelerate the approval of generic drugs by avoiding deficiencies in ANDA submissions. In general, the deficiencies discussed in these articles can be applied to generic ...

Photos courtesy of Yelena Dokic, MD Two patients present with rash eruptions on different parts of the body. Can you correctly identify each case? The terminology for scaly skin conditions dates back ...

Direct access of primary care physicians to dermatologists via asynchronous teledermatology improves a health system’s ability to increase patient access to dermatologic care. Objectives: To determine ...

Dermatologic problems represent about 15%–20% of visits to family physicians and emergency departments. It is often a challenge for a primary care provider to differentiate mundane skin ailments from ...

AUSTIN, Texas--(BUSINESS WIRE)--Epiphany Dermatology, a leading dermatology company committed to improving access to exceptional dermatologic care, announced today it has entered the New Jersey market ...